To further elucidate the molecular action of chrysin in AD with respect to therapeutic efficacy, we focused on the effect exerted by chrysin on TSLP suppression in TNFα-stimulated keratinocytes and in a clinically relevant animal model with AD-like skin lesions induced upon DNCB challenge. Here, TSLP is linked to Alzheimer disease.